文献速递主动脉疾病

腹主动脉瘤血管腔内修复术后Ib型内漏的发生率、危险因素及预后影响:范围综述

Incidence, Risk Factors, and Prognostic Impact of Type Ib Endoleak Following Endovascular Repair for Abdominal Aortic Aneurysm: Scoping Review.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-06-24

本范围综述评估腹主动脉瘤(AAA)血管腔内修复(EVAR)术后Ib型内漏的发生率、危险因素及其与短长期结局的证据基础。共纳入27篇文章(4项前瞻性注册研究和23项回顾性队列研究),涉及7197例患者,随访12至93个月。Ib型内漏报告频率为0%至8%,相关解剖因素包括髂总动脉(CIA)直径>18 mm需使用>20 mm喇叭形支架腿、CIA锚定区长度<20 mm、明显髂动脉扭曲及初始AAA直径大;50%至100%的Ib型内漏经腔内手段矫正,提供信息的即刻技术成功率为100%。

要点

  • EVAR术后Ib型内漏报告发生率为0%至8%。
  • CIA直径>18 mm需用>20 mm喇叭形支架腿、锚定区<20 mm、髂动脉扭曲及AAA直径大与Ib型内漏风险相关。
  • 50%至100%的Ib型内漏经腔内矫正,即刻技术成功率100%。

核心结论

  • EVAR术后Ib型内漏报告发生率为0%至8%。
  • CIA直径>18 mm或需使用>20 mm喇叭形支架腿、CIA锚定区长度<20 mm、明显髂动脉扭曲及初始AAA直径大可能增加Ib型内漏风险,可能需要替代治疗选择和/或更严格随访。
  • 本范围综述总结了Ib型内漏的频率、危险因素、预后和治疗,并识别了文献中的知识空白以指导进一步研究。

研究设计与样本

  • 范围综述,遵循PRISMA范围综述扩展版进行。
  • 检索Cochrane对照试验中心注册库、MEDLINE、Web of Science核心合集、SciELO引文索引、俄罗斯科学引文索引和KCI韩国期刊数据库。
  • 最终纳入27篇文章(4项前瞻性注册研究和23项回顾性队列研究),涉及7197例患者,随访12至93个月。

主要发现

  • EVAR治疗患者中Ib型内漏报告频率范围为0%至8%。
  • 与Ib型内漏风险相关的患者和/或操作因素包括CIA直径>18 mm需使用>20 mm喇叭形支架腿、CIA锚定区长度<20 mm、明显髂动脉扭曲及初始AAA直径大。
  • 根据研究不同,50%至100%的Ib型内漏经腔内手段矫正,提供信息的研究中报告即刻技术成功率为100%。

局限性

  • 本范围综述识别了文献中的知识空白以指导进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary objectives of this scoping review were to assess the rate of and risk factors for type Ib endoleak and to evaluate the extent of the evidence base that links type Ib endoleak to short and long term outcomes in patients undergoing endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). METHODS: Potentially eligible studies were searched in the Cochrane Central Register of Controlled Trials, MEDLINE, Web of Science Core Collection, SciELO Citation Index, Russian Science Citation Index, and KCI-Korean Journal Database. A scoping review was performed according to PRISMA extension for Scoping Reviews. RESULTS: A total of 27 articles (four prospective registries and 23 retrospective cohort studies) dealing with type Ib endoleak were included in the final analysis. The number of patients reported on was 7 197, with follow up ranging between 12 months and 93 months. The reported frequency of type Ib endoleak in patients treated with EVAR ranged from 0% to 8%, Patient and or procedure related factors associated with risk of type Ib endoleak were (1) common iliac artery (CIA) diameter ˃ 18 mm requiring use of flared stent graft limbs (FLs) ˃ 20 mm, (2) length of CIA landing zone ˂ 20 mm, (3) marked iliac tortuosity, and (4) large initial AAA diameter. Depending on the study, 50 - 100% of type Ib endoleaks were corrected by endovascular means, with a reported immediate technical success of 100% in the studies providing this information. CONCLUSION: Type Ib endoleak after EVAR has been reported to occur in 0 - 8% of cases. Several anatomical features, including CIA diameter ˃ 18 mm or requiring the use of FLs ˃ 20 mm, length of CIA landing zone ˂ 20 mm, marked iliac tortuosity, and large initial AAA diameter, could increase the risk of type Ib endoleak and may require alternative therapeutic options and or more stringent follow up. Therefore, this updated scoping review provides a comprehensive summary of the frequency, risk factors, prognosis, and treatment of type Ib endoleaks, and has identified knowledge gaps in the literature to guide further studies.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zuccon G, D'Oria M, Gonçalves FB, et al. Incidence, Risk Factors, and Prognostic Impact of Type Ib Endoleak Following Endovascular Repair for Abdominal Aortic Aneurysm: Scoping Review. Eur J Vasc Endovasc Surg. 2023. PMID: 37356703. doi:10.1016/j.ejvs.2023.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。